At the same time, STING inhibitors may lead to excessive suppression of the body’s immune system, thus impairing the immune surveillance of tumor cells to increase the risk of tumor occurrence [269], and weakening antiviral and antibacterial responses that could result in severe infections [189]. Here, STING1 is linked to infection.